Been here for a year amusing myself but saw the potential on day one. As a poster has suggested unless someone or somebody in the states is supressing the success of a competitors in CYC, it should go far. Come on, it's being sold already in a dozen countries but the investor knowledge is minimal.
That will change when they hit front page of the Fin Review. The faster streaming in America helped also. As a long termer with cgt savings, daggy but impressive. Sometimes the tortoise beats the IVX's and PAB's but it's damn nice to own them all. And what about BOT. Now we are talking.
- Forums
- ASX - By Stock
- CYC
- Ann: 40 Patient Milestone Achieved For Technegas USFDA Trial
CYC
cyclopharm limited
Add to My Watchlist
0.51%
!
98.0¢

Ann: 40 Patient Milestone Achieved For Technegas USFDA Trial, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
98.0¢ |
Change
-0.005(0.51%) |
Mkt cap ! $108.9M |
Open | High | Low | Value | Volume |
$1.00 | $1.00 | 98.0¢ | $14.16K | 14.33K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 7496 | 97.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
98.0¢ | 21262 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 7496 | 0.970 |
1 | 1500 | 0.950 |
1 | 3120 | 0.930 |
1 | 3000 | 0.915 |
1 | 1090 | 0.910 |
Price($) | Vol. | No. |
---|---|---|
0.980 | 21262 | 1 |
1.000 | 5000 | 1 |
1.020 | 2478 | 1 |
1.025 | 7920 | 1 |
1.040 | 457 | 1 |
Last trade - 16.10pm 07/08/2025 (20 minute delay) ? |
Featured News
CYC (ASX) Chart |